Molecular Modelling of Lanosterol 14α-Demethylase (CYPSl) from Saccharomyces Cerevisiae via Homology with CYP102, a Unique Bacterial Cytochrome P450 Isoform: Quantitative Structure-Activity Relationships (QSARs) within two Related Series of Antifungal Azole Derivatives

References

• Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feycrcisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsnlus I. C., Nebert D. W. P450 supertdmily: update on new sequences. gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–42
   PubMedGoogle Scholar
• Lewis D. F. V. Cytochromes P450: Structure Function and.Mechanism. Taylor & Francis, London 1996
   Google Scholar
• Ortiz Montellano P. R. Cytochromc P450. Plenum, New York 1995
   Google Scholar
• Vanden Bossche H., Willemsens G., Marichal P., Cools W., Lauwers W. The molecular basis for the antifungal activities of N-substituted azole derivatives: focus on R51211. Mode of Action of Antifungal Agents, A. P.J. Trinci, J. F. Ryley. British Mycological Society, London 1984; 321–341, Ch. 5
   Google Scholar
• Janssen P. A.J., Vanden Bossche H. Mode of action of cytochrome P450 mono-oxygenase inhibitors: focus on role derivathes. Arch. Pharm. Chemi. Sci. 1987; 15: 23–40
   Google Scholar
• Yoshida Y., Aoyama Y. Cytochromes P150 in the ergosterol biosynthesis. Frontiers in Biotransformation 1991; 4: 127–148
   Google Scholar
• Schuster I. Ereosterol synthesis: the major target in antimycotic therapy. Frontiers in Biotransformation 1993; 8: 147–185
   Google Scholar
• Vanden Bossche H. Mode of action of pyridine. pyrimidine and azole antifungals. Sterol Biosynthesis Inhibitors, D. Berg, M. Plempel. Ellis Horwood, Chichebter 1988; 79–119
   Google Scholar
• Yoshida Y. P450 oxygenase systems of animal tissues. I. Sterol biosynthesis. Cytochrome P450, T. Omura, V. Ishimura, Y. Fujii-Kuriyama. Kodansha, Tohyo 1993; 93–101
   Google Scholar
• Yoshida Y. P450 monooxygenase system in microorganisms. Cytochrome P450, T. Omura, Y. Ishimua, Y. Fujii-Kuriyame. Kodansha, Tokho 1993; 171–185
   Google Scholar
• Vanden Bossche H., Lauwers W., Willemsens G., Marichal P., Cornelissen F., Cools W. Molecular basis for the antimycotic and antibacterial activity of N-substituted imidazoles and triazoles: the inhibition of isoprenoid biosynthesis. Pest. Sci 1984; 15: 188–198
   Google Scholar
• Vanden Bossche H., Willemsens G., Bellens D., Roels I., Janssen P. A.J. From 14α-demethylase inhibitors in fungal cells to androgen and oestrogen biosynthesis inhibitors in mammalian cells. Biochem. Soc. Trans 1990; 18: 10–13
   PubMedGoogle Scholar
• Vanden Bossche H., Bellens D., Cools W., Gorrens J., Marichal P., Verhoeven H., Willemsens G., De Coster R., Beerens D., Haelterman C., Coene M.-C., Lauwers W., Le Jeune L. Cytochrome P450: target for itraconazole. Drug Devel. Res 1986; 8: 287–298
   Google Scholar
• Coulson C. J., King D. J., Wiseman A. Chemotherapeutic and agrochemical applications of cytochrome P450 ligands. Trends Biochem. Sci 1984; 9: 446–449
   Web of Science ®Google Scholar
• Muller H.-G., Schunck W.-H., Kargel E. Cytochromes P450 in alkane-assim-dating yeasts. Frontiers in Biotransformation 1991; 4: 87–126
   Google Scholar
• Seghezzi W., Meili C., Ruffiner R., Kuenzi R., Sanglard D., Fiechter A. Identification and characterization of additional members of the cytochrome P450 multi-gene family CYP.52 of Cundida tropicalis. DNA Cell Biol 1992; 11: 767–780
   Google Scholar
• Chen C., Kalb V. F., Turi T. G., Loper J. C. Primary structure of the cytochrome P450 lanosterol 14–alpha demethylase gene from Candida tropicalis. DNA 1988; 7: 617–626
   PubMedGoogle Scholar
• Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem 1992; 267: 83–90
   PubMed Web of Science ®Google Scholar
• Ishida N., Aoyama Y., Hatanaka R., Oyama Y., Imajo S., Ishiguro M., Oshima T., Nakazato H., Noguchi T., Maitra U S., Mohan V. P., Sprinson D. B., Yoshida Y. A single amino acid substitution converts cytochrcme P45014DM to an inactive form, cytochrome P45OSg1: Complete primary structures deduced from cloned DNAs. Biochem. Biophys. Res. Commun 1988; 155: 317–323
   PubMed Web of Science ®Google Scholar
• Raag R., Li H., Jones B. C., Poulos T. L. Inhibitor-induced conformational change in cytochrome P450cam. Biochemistry 1993; 32: 4571–4578
   PubMed Web of Science ®Google Scholar
• Morris G. M., Richards W. G. Molecular modelling of the sterol C-14 demethylase of Saccharomyces cerevisiae. Biochem. Soc. Trans. 1991; 19: 793–795
   PubMed Web of Science ®Google Scholar
• Lewis D. F.V., Moereels H. The sequence homologies of cytochrome P450 and active site geometries. J. Computer-Aided Mol. Des 1992; 6: 235–252
   PubMed Web of Science ®Google Scholar
• Ravichandran K. G., Boddupalli S. S., Hasemann C. A., Peterson J. A., Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science 1993; 261: 131–736
   Google Scholar
• Kalb V. F., Woods C. W., Turi T. G., Dey C. R., Sutter T. R., Loper J. C. Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae. DNA 1987; 6: 529–537
   PubMedGoogle Scholar
• Lewis D. F.V., Lee-Robichaud P. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure. J. Steroid Biochem. Mol. Biol 1998; 66: 217–233
   PubMed Web of Science ®Google Scholar
• Peeters O. M., Blaton N. M., De Ranter C. J. The crystal structure of micona-zole. Bull. Soc. Chim. Belg 1979; 88: 265–272
   Google Scholar
• Peeters O. M., Blaton N. M., De Ranter C. J. The crystal structure of ketocona-zole. Acta Crystallographica 1979; 35: 2461–2464
   Google Scholar
• Skrzypczak-Jankun E., Kurumbail R. G. l-Trityl-4–nitroimidazole. Acta Crystallographica 1996; 52: 189–191
   Google Scholar
• Pye G. W., Marriott M. S. Inhibition of sterol C14 demethylation by imidazole-containing antifungals. Sabouradia 1982; 20: 325–329
   PubMedGoogle Scholar
• Pople J. A., Santry D. P., Segal G. A. Approximate self-consistent MO theory. I. Invariant procedures. J. Chem. Phys 1965; 43(suppl.)129–135
   Google Scholar
• Vinter J. G., Davis A., Saunders M. R. Strategic approaches to drug design. I. An integrated software framework for molecular modelling. J. Computer-Aided Mol. Des 1987; 1: 35–51
   Google Scholar
• Tuck S. F., Aoyama Y., Toshida Y., Ortiz de Montellano P. R. Active site topology of Saccharomyces cerevisiae lanosterol 14α-demethylase (CYP51) and its G310D mutant (cytochrome P450SGl). J. Biol. Chem 1992; 267: 13175–13179
   Google Scholar
• Marichal P., Gorrens J., Vanden Bossche H. The action of itraconazole and ketoconazole on growth and sterol synthesis in Aspergillus fumigatus and Aspergillus niger. Sahouradia 1985; 23: 13–21
   Google Scholar
• James M. O., Sloan K. B. Structural features of imidazole derivatives that enhance styrene oxide hydroxylase activity in rat hepatic microsomes. J. Med. Chem 1985; 28: 1120–1124
   Google Scholar
• Ballard S. A., Lodola A., Tarbit M. H. A comparative study of 1–substituted imidazole and 1, 2, 4–triazole antifungal compounds as inhibitors of testosterone hydroxyla-tions catalyzed by mouse hepatic microsomal cytochromes P450. Biochem. Pharmacol 1988; 37: 4643–4651
   PubMed Web of Science ®Google Scholar
• Rodrigues A. D., Gibson G. G., Ioannides C., Parke D. V. Interactions of imidazole antifungal agents with purified cytochrome P450 proteins. Biochem. Pharmacol 1987; 36: 4277–4281
   PubMed Web of Science ®Google Scholar
• Rodrigues A. D., Lewis D. F.V., Ioannides C., Parke D. V. Spectral and kinetics studies of the interaction of imidazole antifungal agents with microsomal cytochrome P450. Xenobiotica 1987; 17: 1315–1327
   Web of Science ®Google Scholar
• Lewis D. F.V., Rodrigues A. D., Ioannides C., Parke D. V. Adverse reactions of imidazole antifungal agents: computer graphic studies of cytochrome P450 interactions. J. Biochem. Toxicol 1989; 4: 231–234
   Google Scholar
• Ortiz Montellano P. R., Correia M. A. Inhibition of cytochrome P450 enzymes. Cytochrome P450, P. R Ortiz de Montellano. Plenum, New York 1995; 305–364, Chapter 9
   Google Scholar
• Correia M. A., Ortiz de Montellano P. R. Inhibitors of cytochrome P450 and possibilities for their therapeutic application. Frontiers in Biotransformation 1993; 8: 74–146
   Google Scholar
• Atkins P. W., Friedman R. S. Molecular Quantum Mechanics. Oxford University Press, Oxford 1997
   Google Scholar
• Pople J. A., Beveridge D. L. Approximate Molecular Orbital Theory. McGraw-Hill, New York 1970
   Google Scholar
• Lewis D. F.V. The calculation of molar polarizabilities by the CNDO/2 method: correlation with the hydrophobic parameter, log, P. J. Comput. Chem 1989; 10: 145–151
   Web of Science ®Google Scholar
• Lewis D. F.V. MO-QSARs: a review of molecular orbital-generated quantitative structure-activity relationships. Prog. Drug Metab 1990; 12: 205–255
   Google Scholar
• Avdeef A. Assessment of distribution-pH profiles. Lipophilicity in Drug Action and Toxicology, V. Pliska, B. Testa, H. van de Waterbeemd. VCH, Weinheim 1996; 109–139
   Google Scholar